Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

NCT05486104 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Ulcerative Colitis

Interventions

DRUG: Hemay005 tablets
DRUG: Hemay005 placebo tablets

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd